Outrun Therapeutics announces launch with $10m seed funding
Pharmaceutical Technology
APRIL 18, 2024
Outrun Therapeutics announced its launch with $10m seed funding to advance a protein stabilisation pipeline focused on E3 ligase inhibitors.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Pharmaceutical Technology
APRIL 18, 2024
Outrun Therapeutics announced its launch with $10m seed funding to advance a protein stabilisation pipeline focused on E3 ligase inhibitors.
pharmaphorum
MARCH 26, 2024
Learn more about the expensive failure to launch of these medications. Aduhelm (aducanumab) and Leqembi are examples of controversial drugs that faced challenges with FDA approval.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmafile
APRIL 9, 2024
This includes the launch of Seaport Therapeutics with $100m oversubscribed series A financing. This financing round included participation from ARCH Venture Partners, Sofinnova Investments and Third Rock Ventures, with […] The post PureTech Health launches Seaport Therapeutics appeared first on Pharmafile.
Fierce Healthcare
APRIL 24, 2024
WebMD Ignite is launching a new suite of tech tools it says will help payers turbocharge their clinical programs. WebMD Ignite is launching a new suite of tech tools it says will help payers turbocharge their clinical programs.
Fierce Healthcare
FEBRUARY 25, 2024
LOS ANGELES — Simple HealthKit is launching a new kidney care program that aims to support health plans in driving better outcomes. | LOS ANGELES — Simple HealthKit is launching a new kidney care program that aims to support health plans in driving better outcomes.
STAT
APRIL 24, 2024
Total revenue was slightly weak overall, but sales were stronger for two newly launched medicines — Leqembi and Skyclarys — that matter most to the biotech’s turnaround effort. Biogen on Wednesday reported first-quarter earnings that beat Wall Street expectations largely on reduced expenses.
pharmaphorum
FEBRUARY 6, 2024
Right after the official launch of the new Apple Vision Pro mixed reality headset, Cedars-Sinai has launched a generative artificial intelligence (genAI) app that will use the technology to provide mental health support for patients.
STAT
APRIL 18, 2024
A new startup focused on creating vaccines for cancers, influenza, and potentially even HIV launched Thursday with $54 million in funding. Corner Therapeutics’ Series A round was led by Ziff Capital Partners, a little-known family office started by billionaire Dirk Ziff.
Fierce Healthcare
JANUARY 18, 2024
As part of an initiative teased last summer, Epic officially launched this week new third-party vendor programs to connect health tech companies with health systems and providers. |
Fierce Pharma
APRIL 1, 2024
government to stockpile and distribute Jynneos, Bavarian Nordic is launching the mpox vaccine into the commercial market. government to stockpile and distribute Jynneos, Bavarian Nordic is launching the mpox vaccine into the commercial market. After years relying on the U.S. After years relying on the U.S.
Fierce Healthcare
MARCH 27, 2024
Are patients taking their medications? | Startup Scriptology launched to bring a new approach to medication management by combining an extended clinical pharmacist team with a technology platform to give patients more guidance and support to help them follow their medication plan.
Pharmacy Times
JANUARY 15, 2024
In 2024, Pharmacy Practice in Focus: Health Systems welcomes the launch of the peer-review process, with this issue containing our first peer-reviewed paper.
Fierce Healthcare
APRIL 3, 2024
Employer-sponsored coverage remains the main way half of Americans secure healthcare, and the Commonwealth Fund said Thursday that it would launch a new task force aimed at addressing affordability | Employer-sponsored coverage remains the main way half of Americans secure care, and the Commonwealth Fund said Thursday that it would launch a new task (..)
Fierce Healthcare
SEPTEMBER 19, 2023
Elevance Health's pharmacy benefit manager, CarelonRx, is launching a new program that aims to make it easier for members to access drug discounts at the pharmacy counter.
STAT
JANUARY 30, 2024
Ultima Genomics, an upstart some observers have called a “ dark horse ” in the world of DNA sequencing, will soon launch a line of high-power instruments that can read a human genome for as little as $100, the company’s leadership told STAT. The sequencer, dubbed the UG 100, is a $1.5
Fierce Healthcare
FEBRUARY 13, 2024
Redesign Health, a healthcare startup creator, is reducing its workforce, cutting 77 staff positions, as it slows the pace of new company launches this year, Fierce Healthcare has learned.
pharmaphorum
APRIL 24, 2024
BeiGene has claimed a second EU approval for PD-1 inhibitor tislelizumab in non-small cell lung cancer (NSCLC), opening the door to the first launches of the drug outside China.
STAT
MARCH 6, 2024
Headspace, which has built a growing digital health business around mindfulness, is joining forces with Meta to launch a meditation app for Quest, the social media giant’s virtual reality headset.
STAT
FEBRUARY 14, 2024
After three years being incubated by California VC Westlake Village BioPartners, a new biotech launched Wednesday with $135 million and plans to compete with Vertex Pharmaceuticals. The startup is called Latigo Biotherapeutics, and it’s launching having already started a Phase 1 trial for a non-opioid pain medicine, LTG-001.
Fierce Pharma
APRIL 16, 2024
Despite a pair of clinical misfires in 2023, argenx has stuck by the thesis that its star drug Vyvgart, also known as efgartigimod, could tackle a wide array of autoimmune diseases linked to immuno | Argenx is bolstering its case for Vyvgart’s CIDP potential and preparing for a possible launch later this year—all while the company continues to prove (..)
pharmaphorum
JANUARY 10, 2024
AbbVie has launched its Produodopa therapy for Parkinson’s disease onto the market in the EU, becoming the first and only 24-hour subcutaneous infusion therapy for the neurodegenerative disorder.
Pharmacy Times
FEBRUARY 9, 2024
"Pharmacy Practice in Focus: Oncology" welcomes the launch of the peer-review process.
BioPharm
NOVEMBER 6, 2023
The Alliance for mRNA Medicines (AMM) was officially launched at the 11th International mRNA Health Conference in Berlin, Germany.
Fierce Pharma
APRIL 24, 2024
While Biogen’s Chris Viehbacher figures the company is “turning the corner” after several recent setbacks—thanks in large part to accelerating launches of new drugs like Leqembi and Skyclarys—the C | While Biogen’s Chris Viehbacher figures the company is “turning the corner” after several recent setbacks, the CEO admitted Wednesday that there’s still (..)
Pharmaceutical Technology
DECEMBER 6, 2023
Seattle Children's launched BrainChild Bio to focus on expediting the development of CAR T-cell therapies in central nervous system tumours.
pharmaphorum
JANUARY 9, 2024
Amazon has launched an initiative with Omada Health at JPM that makes it easier for patients to discover and enrol in digital health benefit programmes
Outsourcing Pharma
APRIL 25, 2024
A recent Deloitte report revealed that 36% of healthcare product launches fell short of achieving 80% of their sales targets within the first two years.
Fierce Healthcare
APRIL 15, 2024
Virtual care and health navigation company Included Health plans to launch a virtual-first specialty care clinic to give its members easier access to more than 4,000 specialist physicians, support | Virtual care and health navigation company Included Health plans to launch a virtual-first specialty care clinic to give its members easier access to more (..)
Drug Store News
DECEMBER 13, 2023
General Mills is launching new products across its Trix, Cheerios, Lucky Charms, Nature Valley and Reeseâs Puffs lines.
Fierce Healthcare
JUNE 23, 2023
Amazon Web Services launched a new innovation center focused on generative AI backed by a $100 million investment, its most recent bid to keep up with the AI race. Amazon's cloud unit launched the AWS Generative AI Innovation Center with a $100 million investment, its most recent bid to keep up with the AI race.
Fierce Pharma
MARCH 26, 2024
Bluebird bio reported progress of its launch of three gene therapies and said it will have to refile financial statements because of accounting errors
Fierce Pharma
MARCH 18, 2024
As bluebird bio works to make the most of three gene therapy launches, cash-flow concerns have been looming over the drugmaker. | The funding should extend bluebird bio's cash runway through the first quarter of 2026 as it advances three gene therapy launches.
Mission-Driven Marketing Blog
APRIL 23, 2024
Tapp Network Launches Tapp Green to Digitally Transform the $83 Billion Green Tech Industry with Advanced Marketing and Technology Solutions Wilmington, DE - April 18, 2024 - Amidst the explosive growth of the green technology sector, fueled by the Inflation Reduction Act (IRA) and Bipartisan Infrastructure Law (BIL), Tapp Network, a purpose-driven (..)
Fierce Pharma
APRIL 15, 2024
Boehringer Ingelheim’s 2023 was largely marked by the highly anticipated launch of its Cyltezo, the first interchangeable biosimilar to AbbVie’s Humira. | The company's late-stage pipeline focuses on oncology, cardiorespiratory diseases, mental health and cardiovascular-renal-metabolic conditions.
Fierce Healthcare
OCTOBER 16, 2023
The National Community Pharmacists Association (NCPA) has launched the latest salvo in its battle with pharmacy benefit managers over controversial fees. | The National Community Pharmacists Association has launched the latest salvo in its battle with pharmacy benefit managers over controversial fees.
Fierce Healthcare
DECEMBER 20, 2023
Knownwell, an integrated primary and obesity care provider, is launching a new teen program for weight management. | The new program aims to create a patient-focused environment to uncover and treat the root cause of early obesity.
pharmaphorum
JANUARY 7, 2024
Eli Lilly has launched a new website-based access programme for some drugs like its new obesity therapy Zepbound, opening up a new direct-to-consumer (DTC) channel that
Drug Store News
JANUARY 10, 2024
On the heels of launching its new Better Screen UV Serum, Kiehl’s shared that it has been named the official SPF partner of Jackson Hole Mountain Resort for 2024.
Fierce Healthcare
JANUARY 10, 2024
Elevance Health is launching a new initiative that aims to put smartphones in the hands of Medicaid members who otherwise cannot connect to virtual services. In the wake of the COVID-19 pandemic, virtual care and digital health tools are more popular than ever.
Fierce Pharma
FEBRUARY 8, 2024
This week on “The Top Line,” we explore the most anticipated drug launches of 2024. This week on “The Top Line,” we explore the most anticipated drug launches of 2024.
Outsourcing Pharma
MARCH 26, 2024
Today (March 26) One2Treat, a new innovative start-up offering progressive digital health solutions, has launched a pioneering approach addressing two of the most strategic challenges in the biopharma industry today.
Fierce Healthcare
OCTOBER 31, 2023
Cleveland Clinic plans to launch a drone delivery service to bring certain medications directly to patients’ homes, starting in 2025. | Cleveland Clinic plans to launch a drone delivery service to bring certain medications directly to patients’ homes, starting in 2025.
Drug Store News
JANUARY 31, 2024
and Craig Dubitsky, founder of the eos and hello products brands, have launched happy Products. Robert Downey Jr.
Hospital Pharmacy Europe
SEPTEMBER 8, 2023
Users of the Hospital Pharmacy Europe website can now enjoy upgraded functionality with the launch of a new notification system. This complements the existing notification system built into the Hospital Pharmacy Europe App, which was launched in summer 2022 and is available on iOS and Android.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content